Learning Objectives:
- At the conclusion of this activity, participants will be able to understand the rationale for treatment of hemodynamically significant PDA
-- At the conclusion of this activity, participants will be able to discuss the relative benefits and risks of different medications for PDA treatment
-- At the conclusion of this activity, participants will be able to understand the concept and limitations of network meta-analyses, specifically using SUCRA values (surface under the cumulative ranking curve)
Session date:
10/01/2020 - 1:30pm to 3:30pm CDT
Add to calendar:
- 2.00 AMA PRA Category 1 Credit™
- 2.00 Participation
Speaker Name:
Annie Wang